292 related articles for article (PubMed ID: 29929600)
21. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
Kondrackiene J; Beuers U; Kupcinskas L
Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
[TBL] [Abstract][Full Text] [Related]
23. BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Richards D; Storey J; Dukes G; Gilchrist K; Vallow S; Alexander GJ; Corrigan M; Hirschfield GM; Jones DE
BMC Gastroenterol; 2016 Jul; 16(1):71. PubMed ID: 27431238
[TBL] [Abstract][Full Text] [Related]
24. Jaundice associated pruritis: a review of pathophysiology and treatment.
Bassari R; Koea JB
World J Gastroenterol; 2015 Feb; 21(5):1404-13. PubMed ID: 25663760
[TBL] [Abstract][Full Text] [Related]
25. Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Thompson D; Richards D; Storey J; Dukes GE; Corrigan M; Oude Elferink RP; Beuers U; Hirschfield GM; Jones DE
Lancet; 2017 Mar; 389(10074):1114-1123. PubMed ID: 28187915
[TBL] [Abstract][Full Text] [Related]
26. [Pruritus associated with cholestasis].
Terán A; Fábrega E; Pons-Romero F
Gastroenterol Hepatol; 2010 Apr; 33(4):313-22. PubMed ID: 19836105
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Tandon P; Rowe BH; Vandermeer B; Bain VG
Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis and treatment of pruritus in patients with cholestasis].
Schirrmacher S; Blumenstein I; Stein J
Z Gastroenterol; 2003 Mar; 41(3):259-62. PubMed ID: 12664347
[TBL] [Abstract][Full Text] [Related]
29. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
Chang Y; Golkar L
Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
[TBL] [Abstract][Full Text] [Related]
30. Itch in systemic disease: therapeutic options.
Greaves MW
Dermatol Ther; 2005; 18(4):323-7. PubMed ID: 16297004
[TBL] [Abstract][Full Text] [Related]
31. Safety considerations for the management of cholestatic itch.
Trivella J; Levy C
Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
[No Abstract] [Full Text] [Related]
32. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
[TBL] [Abstract][Full Text] [Related]
33. The pruritus of cholestasis.
Bergasa NV; Jones EA
Semin Liver Dis; 1993 Nov; 13(4):319-27. PubMed ID: 8303314
[No Abstract] [Full Text] [Related]
34. Pruritus in Chronic Liver Disease.
Selim R; Ahn J
Clin Liver Dis; 2023 Feb; 27(1):47-55. PubMed ID: 36400466
[TBL] [Abstract][Full Text] [Related]
35. Pruritus and cholestasis: therapeutic options.
Gillespie DA; Vickers CR
J Gastroenterol Hepatol; 1993; 8(2):168-73. PubMed ID: 8471755
[TBL] [Abstract][Full Text] [Related]
36. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
37. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
Eisendle K; Müller H; Ortner E; Talasz H; Graziadei I; Vogel W; Höpfl R
J Gastroenterol Hepatol; 2011 Apr; 26(4):716-21. PubMed ID: 21155876
[TBL] [Abstract][Full Text] [Related]
38. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
39. Rifampicin as treatment for pruritus in malignant cholestasis.
Price TJ; Patterson WK; Olver IN
Support Care Cancer; 1998 Nov; 6(6):533-5. PubMed ID: 9833303
[TBL] [Abstract][Full Text] [Related]
40. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
